ScholarIQanswers from OpenAlex
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
PaperCitations, authors & open-access status
A Phase 3 Trial of Bevacizumab in Ovarian Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does A Phase 3 Trial of Bevacizumab in Ovarian Cancer have?
ScholarIQcitation count
A Phase 3 Trial of Bevacizumab in Ovarian Cancer has 2,162 citations in the OpenAlex counts ScholarIQ stores.
When was A Phase 3 Trial of Bevacizumab in Ovarian Cancer published?
ScholarIQyear
A Phase 3 Trial of Bevacizumab in Ovarian Cancer has 2011 year in the ScholarIQ index.
What is the open-access status of A Phase 3 Trial of Bevacizumab in Ovarian Cancer?
ScholarIQoa status
A Phase 3 Trial of Bevacizumab in Ovarian Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of A Phase 3 Trial of Bevacizumab in Ovarian Cancer?
ScholarIQdoi
The DOI for A Phase 3 Trial of Bevacizumab in Ovarian Cancer is on the source record.
What is the PMID of A Phase 3 Trial of Bevacizumab in Ovarian Cancer?
ScholarIQpmid
The PMID for A Phase 3 Trial of Bevacizumab in Ovarian Cancer is on the source record.
What is the OpenAlex record for A Phase 3 Trial of Bevacizumab in Ovarian Cancer?
ScholarIQopenalex
The OpenAlex for A Phase 3 Trial of Bevacizumab in Ovarian Cancer is on the source record.